Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan

authors:

avatar Kamiar Alaei 1 , 2 , 3 , 4 , * , avatar Mohammad Sarwar 1 , 2 , avatar Shao Chiu Juan 3 , avatar Arash Alaei 1 , 4

Global Institute for Health and Human Rights (GIHHR), University at Albany, New York, United States
Department of Public Administration and Policy, Rockefeller College, University at Albany, New York, United States
School of Criminal Justice, University at Albany, New York, United States
Department of Health Policy, Management and Behavior, School of Public Health, University at Albany, New York, United States

how to cite: Alaei K, Sarwar M, Juan S C, Alaei A. Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan. Hepat Mon. 2016;16(11):e41262. https://doi.org/10.5812/hepatmon.41262.

References

  • 1.

    Kabir A. Pakistan: A Cirrhotic State? Lancet. 2004;364(9448):1843-4. [PubMed ID: 15565744]. https://doi.org/10.1016/S0140-6736(04)17458-8.

  • 2.

    Qureshi H. Pakistan: Prevention & control of viral hepatitis. Available from: http://www.viralhepatitisaction.org/sites/default/files/AASLD%20Humas%20presentation%203%20Nov.pdf.

  • 3.

    Akbar HII, Rehman U, Butt S, Yousef MZ, Rafique S. Hepatitis C Virus Infection: A Review of the Current and Future Aspects and Concerns in Pakistan National Center of Excellence in Molecular Biology University of Punjab. J General Molecul Virol. 2009;1(2):12-8.

  • 4.

    Merat S, Poustchi H. Hepatitis C in Iran. How extensive of a problem is it? Arch Iran Med. 2012;15(5):268. [PubMed ID: 22519372].

  • 5.

    Sibley AHK, Abourached A, Lesmana LA, Makara M, Jafri W. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm. J Viral Hepat. 2015;3. https://doi.org/10.1111/jvh.12476.

  • 6.

    Karamat KA. Problem, Prevalence and Prevention of Viral Hepatitis in Pakistan. J Viral Hepat.

  • 7.

    Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World J Gastroenterol. 2016;22(4):1684-700. [PubMed ID: 26819533]. https://doi.org/10.3748/wjg.v22.i4.1684.

  • 8.

    Khan AA, Saleem M, Qureshi H, Jooma R, Khan A. Comparison of need and supply of syringes for therapeutic injections in Pakistan. J Pak Med Assoc. 2012;62(11):1149-53. [PubMed ID: 23866401].

  • 9.

    Jiwani NGR. A Silent Storm: Hepatitis C in Pakistan. J Pak Med Stud.

  • 10.

    Abbas M, Hussain MF, Raza S, Shazi L. Frequency and awareness of hepatitis B and C in visitors of Hepatitis Awareness Mela. J Pak Med Assoc. 2010;60(12):1069-71. [PubMed ID: 21381568].

  • 11.

    Aslam M, Taj T, Ali A, Mirza W, Ali H, Dar MI, et al. Needle stick injuries among health care workers of public sector tertiary care hospitals of Karachi. J Coll Physicians Surg Pak. 2010;20(3):150-3. [PubMed ID: 20392374].

  • 12.

    Khan AJLS, Fikree F, Karim A, Obaid S, Dellawala S. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. National Center for Biotechnology Information; 2000.

  • 13.

    Yakoob J, Jafri W, Siddiqui S, Riaz M. Dengue fever with hepatitis E and hepatitis A infection. J Pak Med Assoc. 2009;59(3):176-7. [PubMed ID: 19288948].

  • 14.

    Janjua NZ. Injection practices and sharp waste disposal by general practitioners of Murree, Pakistan. J Pak Med Assoc. 2003;53(3):107-11. [PubMed ID: 12779025].